Navigation Links
Late peak may have prevented severe flu season from becoming worse

The 2004-2005 flu season was at least as severe as the 2003-2004 season, but peaked later according to data from Solucient, a leading provider of healthcare information. This later peak may have prevented the most recent flu season from being even worse.

A flu season's severity is reflected in hospital admissions for community-acquired pneumonia (CAP), one of the most common complications of the flu. Solucient analyzed CAP discharge data from October 2002 through March 2005. The data was provided by ACTrackerTM, an online tool that provides national estimates of hospital and drug utilization approximately 45 days after the end of each month, making the estimates the most timely and current of their kind.

In the 2004-2005 flu season, daily CAP discharges peaked at an average of about 7,000 and 8,000, respectively, in January/February 2005 compared to the previous flu season's December 2003/January 2004 peak. Both these seasons had approximately 31 percent more hospital discharges than the 2002-2003 flu season.

Due to an unusual shortage of flu vaccine, the later peak of the 2004-2005 flu season may have been beneficial, allowing public health officials more time to reallocate and administer the limited supply of vaccine to those most in need -- the elderly and children. This extra time could have been responsible for preventing many more people from becoming ill than would have been expected under the circumstances if the flu peaked at the same time it did the year before.

###

To see a graph showing hospital CAP admissions for 2002-2005, go to http://www.solucient.com/trendtracker


'"/>

Source:Solucient, LLC


Page: 1

Related biology news :

1. Study reveals genomics of inflammation from severe injury
2. Study shows pine bark naturally decreases severe chronic venous insufficiency
3. New treatment for severe malaria
4. Highly concentrated botulinum preparation for cosmetic injections can result in severe illness
5. Hopkins scientists link immune response to ghost parasites and severely congested sinuses
6. New findings could lead to vaccine for severe malaria
7. MRSA toxin acquitted: Study clears suspected key to severe bacterial illness
8. Mutant gene causes severe kidney disease in infants
9. Stanford-led study closes in on genes that may predispose some people to severe depression
10. Amazon rainforest greens up in the dry season
11. Air travel and flu: Post-9/11 restrictions delayed start of season
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/3/2017)... April 3, 2017  Data captured by ... platform, detected a statistically significant association between ... to treatment and objective response of cancer ... to predict whether cancer patients will respond ... as well as to improve both pre-infusion potency ...
(Date:3/29/2017)... March 29, 2017  higi, the health IT company ... North America , today announced a Series ... acquisition of EveryMove. The new investment and acquisition accelerates ... tools to transform population health activities through the collection ... higi collects and secures data today on ...
(Date:3/24/2017)... -- Research and Markets has announced the addition of ... - Industry Forecast to 2025" report to their offering. ... The Global Biometric Vehicle ... around 15.1% over the next decade to reach approximately $1,580 million ... estimates and forecasts for all the given segments on global as ...
Breaking Biology News(10 mins):
(Date:4/26/2017)... ... April 26, 2017 , ... WonderWorks, ... NASA to showcase the future of deep space exploration and inspire space enthusiasts. ... Orion spacecraft and includes a guest appearance by former Shuttle Astronaut Don Thomas. ...
(Date:4/26/2017)... (PRWEB) , ... April 26, 2017 , ... ... headlines and drive high-level conversations among healthcare industry stakeholders, the discussion surrounding the ... – taking place May 15-18, 2017 in Los Angeles, Calif. Hosted by the ...
(Date:4/25/2017)... April 25, 2017 Providence ... licensed its novel immune-modulating technology to an undisclosed global ... allergy. Tregitopes, pronounced T·rej·itopes, are a ... by EpiVax CEO Annie De Groot ... immunoglobulin G, an autoimmune disease therapy, Tregitopes are ...
(Date:4/24/2017)... NEW YORK , April 24, 2017  Dante Labs ... interpretation at only EUR 850 (ca. $900). While American individuals ... marks the first time Europeans can access WGS below EUR ... which are crucial to leveraging genetic information to make informed ... more. ...
Breaking Biology Technology: